{"id":"https://openalex.org/W2320744367","doi":"https://doi.org/10.1097/cad.0b013e3283648c69","title":"Antiproliferative effect of benzimidazole anthelmintics albendazole, ricobendazole, and flubendazole in intestinal cancer cell lines","display_name":"Antiproliferative effect of benzimidazole anthelmintics albendazole, ricobendazole, and flubendazole in intestinal cancer cell lines","alternate_titles":[],"publication_year":2013,"publication_date":"2013-07-24","ids":{"openalex":"https://openalex.org/W2320744367","doi":"https://doi.org/10.1097/cad.0b013e3283648c69","mag":"2320744367","pmid":"https://pubmed.ncbi.nlm.nih.gov/23884106"},"language":"en","primary_location":{"id":"doi:10.1097/cad.0b013e3283648c69","doi":"https://doi.org/10.1097/cad.0b013e3283648c69","is_oa":false,"landing_page_url":"https://doi.org/10.1097/cad.0b013e3283648c69","pdf_url":null,"source":{"id":"https://openalex.org/S158028025","display_name":"Anti-Cancer Drugs","issn_l":"0959-4973","issn":["0959-4973","1473-5741"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-Cancer Drugs","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2320744367"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5057502131","display_name":"V\u011bra Kr\u00e1lov\u00e1","orcid":"https://orcid.org/0000-0001-5971-4110","observed_orcids":["https://orcid.org/0000-0001-5971-4110"]},"institutions":[{"id":"https://openalex.org/I21250087","display_name":"Charles University","ror":"https://ror.org/024d6js02","country_code":"CZ","type":"education","lineage":["https://openalex.org/I21250087"]}],"countries":["CZ"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"V\u011bra Kr\u00e1lov\u00e1","raw_affiliation_strings":["Department of Medical Biology and Genetics, Faculty of Medicine, Charles University in Prague, Hradec Kr\u00e1lov\u00e9, Czech Republic. kralovav@lfhk.cuni.cz","e-mail: [email\u00a0protected]","fax: +42 495 513 597","to V\u011bra Kr\u00e1lov\u00e1, Department of Medical Biology and Genetics, Faculty of Medicine, Charles University in Prague, \u0160imkova 870, Hradec Kr\u00e1lov\u00e9, CZ-500 38, Czech Republic Tel: +42 495 816 252"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Biology and Genetics, Faculty of Medicine, Charles University in Prague, Hradec Kr\u00e1lov\u00e9, Czech Republic. kralovav@lfhk.cuni.cz","institution_ids":["https://openalex.org/I21250087"]},{"raw_affiliation_string":"e-mail: [email\u00a0protected]","institution_ids":[]},{"raw_affiliation_string":"fax: +42 495 513 597","institution_ids":[]},{"raw_affiliation_string":"to V\u011bra Kr\u00e1lov\u00e1, Department of Medical Biology and Genetics, Faculty of Medicine, Charles University in Prague, \u0160imkova 870, Hradec Kr\u00e1lov\u00e9, CZ-500 38, Czech Republic Tel: +42 495 816 252","institution_ids":["https://openalex.org/I21250087"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013077830","display_name":"Veronika Hanu\u0161ov\u00e1","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I21250087","display_name":"Charles University","ror":"https://ror.org/024d6js02","country_code":"CZ","type":"education","lineage":["https://openalex.org/I21250087"]}],"countries":["CZ"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Veronika Hanu\u0161ov\u00e1","raw_affiliation_strings":["Department of Biochemical Sciences, Faculty of Pharmacy, Charles University in Prague, Hradec Kr\u00e1lov\u00e9, Czech Republic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biochemical Sciences, Faculty of Pharmacy, Charles University in Prague, Hradec Kr\u00e1lov\u00e9, Czech Republic","institution_ids":["https://openalex.org/I21250087"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013486766","display_name":"Petra Sta\u0148kov\u00e1","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I21250087","display_name":"Charles University","ror":"https://ror.org/024d6js02","country_code":"CZ","type":"education","lineage":["https://openalex.org/I21250087"]}],"countries":["CZ"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Petra Sta\u0148kov\u00e1","raw_affiliation_strings":["Department of Biochemical Sciences, Faculty of Pharmacy, Charles University in Prague, Hradec Kr\u00e1lov\u00e9, Czech Republic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biochemical Sciences, Faculty of Pharmacy, Charles University in Prague, Hradec Kr\u00e1lov\u00e9, Czech Republic","institution_ids":["https://openalex.org/I21250087"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013199611","display_name":"Kate\u0159ina Knoppov\u00e1","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I21250087","display_name":"Charles University","ror":"https://ror.org/024d6js02","country_code":"CZ","type":"education","lineage":["https://openalex.org/I21250087"]}],"countries":["CZ"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kate\u0159ina Knoppov\u00e1","raw_affiliation_strings":["Department of Biochemical Sciences, Faculty of Pharmacy, Charles University in Prague, Hradec Kr\u00e1lov\u00e9, Czech Republic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biochemical Sciences, Faculty of Pharmacy, Charles University in Prague, Hradec Kr\u00e1lov\u00e9, Czech Republic","institution_ids":["https://openalex.org/I21250087"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047439710","display_name":"Krist\u00fdna \u010c\u00e1\u0148ov\u00e1","orcid":"https://orcid.org/0000-0002-0331-4158","observed_orcids":["https://orcid.org/0000-0002-0331-4158"]},"institutions":[{"id":"https://openalex.org/I21250087","display_name":"Charles University","ror":"https://ror.org/024d6js02","country_code":"CZ","type":"education","lineage":["https://openalex.org/I21250087"]}],"countries":["CZ"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Krist\u00fdna \u010c\u00e1\u0148ov\u00e1","raw_affiliation_strings":["Department of Biochemical Sciences, Faculty of Pharmacy, Charles University in Prague, Hradec Kr\u00e1lov\u00e9, Czech Republic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biochemical Sciences, Faculty of Pharmacy, Charles University in Prague, Hradec Kr\u00e1lov\u00e9, Czech Republic","institution_ids":["https://openalex.org/I21250087"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5004289752","display_name":"Lenka Sk\u00e1lov\u00e1","orcid":"https://orcid.org/0000-0003-0741-3871","observed_orcids":["https://orcid.org/0000-0003-0741-3871"]},"institutions":[{"id":"https://openalex.org/I21250087","display_name":"Charles University","ror":"https://ror.org/024d6js02","country_code":"CZ","type":"education","lineage":["https://openalex.org/I21250087"]}],"countries":["CZ"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Lenka Sk\u00e1lov\u00e1","raw_affiliation_strings":["Department of Biochemical Sciences, Faculty of Pharmacy, Charles University in Prague, Hradec Kr\u00e1lov\u00e9, Czech Republic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biochemical Sciences, Faculty of Pharmacy, Charles University in Prague, Hradec Kr\u00e1lov\u00e9, Czech Republic","institution_ids":["https://openalex.org/I21250087"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5057502131"],"corresponding_institution_ids":["https://openalex.org/I21250087"],"apc_list":null,"apc_paid":null,"fwci":1.5451,"has_fulltext":false,"cited_by_count":67,"citation_normalized_percentile":{"value":0.79765245,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"24","issue":"9","first_page":"911","last_page":"919"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.5419999957084656,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.5419999957084656,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10492","display_name":"Microtubule and mitosis dynamics","score":0.25929999351501465,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.11620000004768372,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/albendazole","display_name":"albendazole","score":0.8420000076293945},{"id":"https://openalex.org/keywords/ricobendazole","display_name":"ricobendazole","score":0.996999979019165},{"id":"https://openalex.org/keywords/flubendazole","display_name":"flubendazole","score":1.0},{"id":"https://openalex.org/keywords/benzimidazole-anthelmintics","display_name":"benzimidazole anthelmintics","score":0.9940000176429749},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":0.8389999866485596},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.46299999952316284},{"id":"https://openalex.org/keywords/antiproliferative-activity","display_name":"antiproliferative activity","score":0.9580000042915344},{"id":"https://openalex.org/keywords/tubulin-polymerization-inhibition","display_name":"tubulin polymerization inhibition","score":0.9039999842643738},{"id":"https://openalex.org/keywords/g2-m-cell-cycle-arrest","display_name":"G2/M cell cycle arrest","score":0.8989999890327454},{"id":"https://openalex.org/keywords/cytostatic-effect","display_name":"cytostatic activity","score":0.8790000081062317},{"id":"https://openalex.org/keywords/drug-repurposing","display_name":"drug repurposing","score":0.7170000076293945}],"concepts":[{"id":"https://openalex.org/C2777065887","wikidata":"https://www.wikidata.org/wiki/Q411629","display_name":"Albendazole","level":2,"score":0.8900579810142517},{"id":"https://openalex.org/C2778484023","wikidata":"https://www.wikidata.org/wiki/Q415190","display_name":"Benzimidazole","level":2,"score":0.7859521508216858},{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.6817710399627686},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6443326473236084},{"id":"https://openalex.org/C2776908094","wikidata":"https://www.wikidata.org/wiki/Q572294","display_name":"Anthelmintic","level":2,"score":0.5862878561019897},{"id":"https://openalex.org/C53227056","wikidata":"https://www.wikidata.org/wiki/Q189152","display_name":"Viability assay","level":3,"score":0.5843172669410706},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.46846407651901245},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.4661494493484497},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.459975004196167},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.3715943694114685},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3692546486854553},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3398633599281311},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3201944828033447},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.30007055401802063},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1169348955154419},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.10922977328300476},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.05601981282234192},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0},{"id":"https://openalex.org/C18903297","wikidata":"https://www.wikidata.org/wiki/Q7150","display_name":"Ecology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000871","descriptor_name":"Anthelmintics","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000972","descriptor_name":"Antineoplastic Agents, Phytogenic","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D002470","descriptor_name":"Cell Survival","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007414","descriptor_name":"Intestinal Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008463","descriptor_name":"Mebendazole","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D008463","descriptor_name":"Mebendazole","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D008870","descriptor_name":"Microtubules","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D015766","descriptor_name":"Albendazole","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D015766","descriptor_name":"Albendazole","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D016195","descriptor_name":"G2 Phase","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D020128","descriptor_name":"Inhibitory Concentration 50","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D050257","descriptor_name":"Tubulin Modulators","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D055550","descriptor_name":"Protein Stability","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/cad.0b013e3283648c69","doi":"https://doi.org/10.1097/cad.0b013e3283648c69","is_oa":false,"landing_page_url":"https://doi.org/10.1097/cad.0b013e3283648c69","pdf_url":null,"source":{"id":"https://openalex.org/S158028025","display_name":"Anti-Cancer Drugs","issn_l":"0959-4973","issn":["0959-4973","1473-5741"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-Cancer Drugs","raw_type":"journal-article"},{"id":"pmid:23884106","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23884106","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-cancer drugs","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":26,"referenced_works":["https://openalex.org/W1964437947","https://openalex.org/W1971579914","https://openalex.org/W1973514430","https://openalex.org/W1990852576","https://openalex.org/W2006713454","https://openalex.org/W2011737545","https://openalex.org/W2028337996","https://openalex.org/W2029118887","https://openalex.org/W2040433810","https://openalex.org/W2041525960","https://openalex.org/W2051878786","https://openalex.org/W2059863275","https://openalex.org/W2062166509","https://openalex.org/W2074347542","https://openalex.org/W2082419433","https://openalex.org/W2082776191","https://openalex.org/W2090458582","https://openalex.org/W2092666043","https://openalex.org/W2093855538","https://openalex.org/W2099365945","https://openalex.org/W2112284988","https://openalex.org/W2118606589","https://openalex.org/W2135103304","https://openalex.org/W2141331332","https://openalex.org/W2145535413","https://openalex.org/W2417468037"],"related_works":["https://openalex.org/W7135790306","https://openalex.org/W6927264275","https://openalex.org/W7135613363","https://openalex.org/W1550516877","https://openalex.org/W3158781134","https://openalex.org/W3153324954","https://openalex.org/W7135650996","https://openalex.org/W2098047267","https://openalex.org/W2996375815","https://openalex.org/W4387938083"],"abstract_inverted_index":{"This":[0],"study":[1],"aimed":[2],"to":[3,17,123],"test":[4],"the":[5,28,31,82,106,130,179],"antiproliferative":[6,55],"effect":[7,56,176],"of":[8,30,57,148,181],"three":[9,72],"benzimidazole":[10,167],"anthelmintics":[11],"in":[12,96,105,121,183],"intestinal":[13,37,184],"cancer":[14,38,185],"cells":[15],"and":[16,44,49,64,81,90,99,125,138,143,150,170,177],"investigate":[18],"whether":[19],"these":[20],"drugs,":[21],"which":[22],"inhibit":[23],"tubulin":[24],"polymerization,":[25],"can":[26],"potentiate":[27,178],"efficacy":[29,180],"microtubule-stabilizing":[32],"drug":[33],"paclitaxel":[34],"(PTX).":[35],"Four":[36],"cell":[39,77,87,93,103,118,153],"lines,":[40],"SW480,":[41],"SW620,":[42],"HCT8,":[43],"Caco2,":[45],"with":[46,67,127,159,161],"different":[47,73],"origins":[48],"growth":[50],"characteristics":[51],"were":[52],"used.":[53],"The":[54,117,165],"albendazole":[58],"(ABZ),":[59],"ricobendazole":[60],"(RBZ),":[61],"flubendazole":[62],"(FLU),":[63],"their":[65],"combinations":[66],"PTX":[68,182],"was":[69,110],"tested":[70],"using":[71],"end-point":[74],"viability":[75,154],"assays,":[76],"cycle":[78],"distribution":[79],"analysis,":[80],"x-CELLigence":[83],"System":[84],"for":[85,136],"real-time":[86],"analysis.":[88],"ABZ":[89,137,169],"FLU":[91,124,139,171],"inhibited":[92],"proliferation":[94],"significantly":[95],"a":[97,173],"concentration-dependent":[98],"time-dependent":[100],"manner":[101],"through":[102],"arrest":[104],"G2/M":[107],"phase.":[108],"RBZ":[109],"not":[111],"effective":[112],"at":[113],"any":[114],"concentration":[115],"tested.":[116],"lines":[119],"differed":[120],"sensitivity":[122],"ABZ,":[126],"HCT8":[128],"being":[129],"most":[131],"sensitive,":[132],"showing":[133],"IC\u2085\u2080":[134],"values":[135],"that":[140],"reached":[141],"0.3":[142],"0.9":[144],"\u03bcmol/l,":[145],"respectively.":[146],"Combinations":[147],"PTX+ABZ":[149],"PTX+FLU":[151],"decreased":[152],"more":[155],"effectively":[156],"when":[157],"compared":[158],"treatment":[160],"individual":[162],"drugs":[163,168],"alone.":[164],"anthelmintic":[166],"show":[172],"significant":[174],"cytostatic":[175],"cells.":[186]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2320744367","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":8},{"year":2022,"cited_by_count":10},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":8},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":6},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
